Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted therapy for lung cancer.

Rajesh Kukunoor1, Jigar Shah, Tarek Mekhail

  • 1Taussig Cancer Center, The Cleveland Clinic Foundation, R35, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

Current Oncology Reports
|June 5, 2003
PubMed
Summary

Lung cancer is a leading cause of death, often due to late diagnosis. Targeted therapies offer new hope for treating metastatic lung cancer by targeting mutated genes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Formulation and Optimization of Leflunomide-Loaded NLC-Gel for Improved Skin Permeation and Anti-Inflammatory Efficacy.

Journal of drug targeting·2026
Same author

Adherence to best practice guidelines for the management of intrahepatic cholangiocarcinoma: results from the CAPBIL study.

The British journal of surgery·2026
Same author

Patient preferences for EGFR mutation-targeted therapies in non-small cell lung cancer, with a focus on Exon 20 insertions.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.

Clinical lung cancer·2024
Same author

Innovations in Nanoemulsion Technology: Enhancing Drug Delivery for Oral, Parenteral, and Ophthalmic Applications.

Pharmaceutics·2024
Same author

PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate.

AAPS PharmSciTech·2024

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer is the primary cause of cancer-related mortality in the United States.
  • Late diagnosis and limited chemotherapy options for metastatic disease contribute to poor outcomes.
  • Advances in understanding gene mutations in cancer have spurred the development of targeted therapies.

Purpose of the Study:

  • To review the current landscape of targeted therapy development for lung cancer.
  • To discuss specific targeted agents being investigated for lung cancer treatment.

Main Methods:

  • Literature review of targeted agents in lung cancer research.
  • Discussion of mechanisms of action for selected targeted therapies.

Main Results:

  • Several targeted agents show promise in preclinical and clinical studies.
  • Targeted therapies aim to inhibit specific molecular pathways driving cancer growth.

Conclusions:

  • Targeted therapies represent a significant advancement in lung cancer treatment.
  • Further research is crucial to optimize the efficacy and application of these agents.

Related Experiment Videos